ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,755Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 887

$420K Total Retail Price of All Prescriptions

Rank: 60 out of 887

694 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 694 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 6,987 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
AMLODIPINE BESYLATE 637 474 1 5
PRAVASTATIN SODIUM 523 414 2 12
OMEPRAZOLE 369 227 3 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 313 241 4 22
HYDROCHLOROTHIAZIDE 263 202 5 10
SIMVASTATIN 243 201 6 3
ALENDRONATE SODIUM 234 205 7 57
METFORMIN HCL 233 159 8 8
LISINOPRIL 221 166 9 4
GLIPIZIDE ER 212 172 10 144
TRIAMTERENE-HCTZ 195 136 11 115
GABAPENTIN 178 93 12 6
FUROSEMIDE 175 128 13 7
AMLODIPINE BESYLATE-BENAZEPRIL 154 127 14 63
TRAMADOL HCL 151 109 15 15
ATORVASTATIN CALCIUM 148 109 16 13
LEVOTHYROXINE SODIUM 147 124 17 9
DONEPEZIL HCL 142 142 18 51
TAMSULOSIN HCL 136 118 19 38
METOPROLOL SUCCINATE 120 94 20 19
FAMOTIDINE 119 85 21 143
HYDRALAZINE HCL 118 100 22 139
PROAIR HFA 117 67 23 39
POTASSIUM CHLORIDE 117 89 23 21
BISOPROLOL-HYDROCHLOROTHIAZIDE 114 97 25 208
CRESTOR 113 82 26 25
JANUVIA 110 84 27 85
METOPROLOL TARTRATE 101 76 28 16
CLONIDINE HCL 99 42 29 76
LOSARTAN-HYDROCHLOROTHIAZIDE 95 81 30 68
DIOVAN HCT 94 69 31 94
ATENOLOL 94 78 31 37
SERTRALINE HCL 88 71 33 32
NIFEDIPINE ER 84 83 34 168
ZOLPIDEM TARTRATE 73 51 35 14
CARVEDILOL 67 55 36 24
BENAZEPRIL-HYDROCHLOROTHIAZIDE 67 33 36 178
HYDROCODONE-ACETAMINOPHEN 65 49 S3 38 1
FLUTICASONE PROPIONATE 63 28 39 29
NEXIUM 60 21 40 18
DILTIAZEM 24HR ER 59 47 41 208
GLIPIZIDE XL 56 49 42 106
PLAVIX 54 50 43 82
METFORMIN HCL ER 52 34 44 50
VENTOLIN HFA 50 30 45 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.